Literature DB >> 15370208

Use of the World Health Organization (WHO) classification of non-Hodgkin's lymphoma in Mumbai, India: a review of 200 consecutive cases by a panel of five expert hematopathologists.

Kikkeri N Naresh1, Beamon Agarwal, Bharat N Nathwani, Jacques Diebold, Kenneth A McLennan, Konrad H Muller-Hermelink, James O Armitage, Dennis D Weisenburger.   

Abstract

This study aims to answer the question whether the World Health Organization (WHO) classification of non-Hodgkin's lymphoma (NHL) can be practised to international standards at the Lymphoma Registry (LR) established at the Tata Memorial Hospital, Mumbai, India. Furthermore, the study aims to identify differences in the distribution of NHL subtypes at this LR (likely to be representative of India) as compared to the rest of the world. A panel of 5 expert hematopathologists from the NHL Classification Project reviewed 200 consecutive NHL cases at the LR in January of 2001. These cases were accrued during August and September, 2000. On all cases, hematoxylin and eosin stains and appropriate immunostains were available for review. The diagnosis made by the host pathologist at the LR (KNN) and the initial diagnosis made by each of the expert hematopathologists was compared with the consensus diagnosis. A consensus diagnosis was made by the 5 experts in 197 cases. The agreement of the host pathologist with the consensus diagnosis was 82% and the agreement of the individual experts with the consensus diagnosis varied from 76-88% (mean 82%). According to the consensus diagnosis, 80% of NHLs were of B-cell type, 18% were of T-cell type, and the immunophenotype could not be determined in the remaining 2% of cases. In conclusion, the WHO classification of NHL was properly utilized at the Lymphoma Registry, Mumbai, India, and geographic differences were noted in the distribution of NHL subtypes at the LR as compared to the rest of the world. Precursor T lymphoblastic leukemia/lymphoma was more common in India (7%) than the rest of the world (1-4%), and indolent B-cell NHLs (29%) were less common than in the West. As compared to China and Japan, peripheral T-cell lymphoma (4.6%), extranodal NK/T cell lymphoma, nasal type (0.5%) and extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT-lymphoma) (2.6%) were less common, but follicular lymphoma (15%) and chronic lymphocytic leukemia/small lymphocytic lymphoma (5%) were more common. This suggests that the distribution of the B-cell and T-cell lymphomas in the Indian population, except for lymphoblastic lymphoma, lies in between the Western world (mainly Caucasian) and the Orientals.

Entities:  

Mesh:

Year:  2004        PMID: 15370208     DOI: 10.1080/10428190410001683679

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  7 in total

1.  Non-Hodgkin lymphoma in childhood and adolescence: frequency and distribution of immunomorphological types from a tertiary care center in South India.

Authors:  Marie Therese Manipadam; Sheila Nair; Auro Viswabandya; Leni Mathew; Alok Srivastava; Mammen Chandy
Journal:  World J Pediatr       Date:  2011-06-01       Impact factor: 2.764

2.  European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis.

Authors:  Thomas Buhr; Konnie Hebeda; Vassiliki Kaloutsi; Anna Porwit; Jon Van der Walt; Hans Kreipe
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

3.  Disease patterns of pediatric non-Hodgkin lymphoma: A study from a developing area in Egypt.

Authors:  Laila M Sherief; Usama R Elsafy; Elhamy R Abdelkhalek; Naglaa M Kamal; Doaa M Youssef; Rabab Elbehedy
Journal:  Mol Clin Oncol       Date:  2014-09-24

4.  Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr Virus positive and negative pediatric non-Hodgkin's lymphoma.

Authors:  Safiye Aktaş; Aydanur Kargi; Nur Olgun; Gulden Diniz; Ayşe Erbay; Canan Vergin
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

5.  Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand.

Authors:  Tawatchai Pongpruttipan; Tanawan Kummalue; Anan Bedavanija; Archrob Khuhapinant; Koichi Ohshima; Fumiko Arakawa; Daisuke Niino; Sanya Sukpanichnant
Journal:  Diagn Pathol       Date:  2011-08-25       Impact factor: 2.644

6.  Flow cytometric immunophenotyping and cell block immunocytochemistry in the diagnosis of primary Non-Hodgkin's Lymphoma by fine-needle aspiration: Experience from a tertiary care center.

Authors:  Tuhin Paul; Upasana Gautam; Arvind Rajwanshi; Ashim Das; Amita Trehan; Pankaj Malhotra; Radhika Srinivasan
Journal:  J Cytol       Date:  2014-07       Impact factor: 1.000

7.  Non-Hodgkin Lymphoma in the Middle East Is Characterized by Low Incidence Rates With Advancing Age.

Authors:  Rafil T Yaqo; Sana D Jalal; Kharaman J Ghafour; Hemin A Hassan; Michael D Hughson
Journal:  J Glob Oncol       Date:  2019-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.